Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 118.90M | £ 96.40M | £ 119.30M | £ 128.00M | £ 109.30M |
Total Assets | £ 566.90M | £ 523.90M | £ 501.60M | £ 450.70M | £ 410.50M |
Total Debt | £ 53.20M | £ 28.90M | £ 62.10M | £ 37.90M | £ 35.20M |
Net Debt | £ -65.70M | £ -67.50M | £ -57.20M | £ -90.10M | £ -74.10M |
Total Liabilities | £ 251.30M | £ 207.50M | £ 222.70M | £ 184.50M | £ 171.00M |
Stockholders Equity | £ 315.60M | £ 316.40M | £ 278.90M | £ 266.20M | £ 239.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |